Levodopa equivalent dose (LED) showed a trend toward reduction in the virtual clinic group (–64.8 ± 265.8 mg) and a slight increase in the in-clinic group (+99.1 ± 315.8 mg), though with high variability and overlapping confidence intervals (Fig. 4b , Supplementary Table 6 ).
← all excerpts
Real-world multicenter assessment of sustained clinical outcomes after digital deep brain stimulation.
1
—
—